Amylyx Pharmaceuticals, Inc. AMLX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s change in other assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported change in other assets of -$1.43M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s change in other assets decreased by 63.0% year-over-year, from -$879K to -$1.43M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.